MedPath

INSTITUTE OF LIVER AND BILIARY SCIENCES

INSTITUTE OF LIVER AND BILIARY SCIENCES logo
๐Ÿ‡ฎ๐Ÿ‡ณIndia
Ownership
-
Employees
-
Market Cap
-
Website

Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients

Not Applicable
Withdrawn
Conditions
Chronic Hepatitis B
Interventions
First Posted Date
2010-12-15
Last Posted Date
2015-06-16
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Registration Number
NCT01260610
Locations
๐Ÿ‡ฎ๐Ÿ‡ณ

Institute of Liver & Biliary Sciences, New Delhi, India

Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial

Not Applicable
Completed
Conditions
Hepatic Encephalopathy
Interventions
First Posted Date
2010-10-11
Last Posted Date
2013-04-04
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
120
Registration Number
NCT01218568
Locations
๐Ÿ‡ฎ๐Ÿ‡ณ

Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in Cirrhosis

Not Applicable
Conditions
Cirrhosis
Interventions
Drug: Placebo
First Posted Date
2010-09-30
Last Posted Date
2019-11-05
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
132
Registration Number
NCT01212250
Locations
๐Ÿ‡ฎ๐Ÿ‡ณ

Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Carvedilol + VSL#3 Versus Endoscopic Variceal Ligation for Primary Prophylaxis of Esophageal Variceal Bleeding in Cirrhotic Patients Non Responder to Carvedilol.

Not Applicable
Completed
Conditions
Cirrhosis
Interventions
Drug: Carvedilol+VSL#3
Procedure: Endoscopic variceal ligation
First Posted Date
2010-09-08
Last Posted Date
2020-05-15
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
40
Registration Number
NCT01196481
Locations
๐Ÿ‡ฎ๐Ÿ‡ณ

Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Early Primary Prophylaxis of Esophageal Varices

Not Applicable
Completed
Conditions
Cirrhosis
Interventions
Drug: Placebo
First Posted Date
2010-09-08
Last Posted Date
2016-06-15
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
140
Registration Number
NCT01196507
Locations
๐Ÿ‡ฎ๐Ÿ‡ณ

Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

ยฉ Copyright 2025. All Rights Reserved by MedPath